Halogenated diarylacetylenes repress c-myc expression in cancer cells
摘要:
Halogenated diarylacetylenes that possess fluorine or chlorine substituents in one aryl ring and N-methylamino or N,N-dimethylamino in the other aryl ring inhibit the proliferation of LS174T colon cancer cells through the repression of c-myc expression and induction of the cyclin-dependent kinase inhibitor-1 (i.e., p21(Wif1/Cip1)) and represent potentially useful antineoplastic agents. (C) 2014 Elsevier Ltd. All rights reserved.
HALOGENATED DIARYLACETYLENES AND METHODS OF TREATING CANCER
申请人:UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
公开号:US20150272908A1
公开(公告)日:2015-10-01
Halogenated diarylacetylenes, e.g., diarylacetylenes having at least one halo substituent in one aryl ring and an amine in the opposing aryl ring, can inhibit the proliferation of LS174T colon cancer cells through the inhibition of c-myc and induction of the cyclin-dependent kinase inhibitor-1 (i.e., p21(Wif1/Cip1)). Such compounds are useful as antineoplastic agents.
Halogenated diarylacetylenes repress c-myc expression in cancer cells
作者:Vitaliy M. Sviripa、Wen Zhang、Liliia M. Kril、Alice X. Liu、Yaxia Yuan、Chang-Guo Zhan、Chunming Liu、David S. Watt
DOI:10.1016/j.bmcl.2014.04.113
日期:2014.8
Halogenated diarylacetylenes that possess fluorine or chlorine substituents in one aryl ring and N-methylamino or N,N-dimethylamino in the other aryl ring inhibit the proliferation of LS174T colon cancer cells through the repression of c-myc expression and induction of the cyclin-dependent kinase inhibitor-1 (i.e., p21(Wif1/Cip1)) and represent potentially useful antineoplastic agents. (C) 2014 Elsevier Ltd. All rights reserved.